Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Optimal Number of Fiducial Marker Implanted With 3D-template Assitance for Stereotactic Body Radiotherapy

NCT06342323 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT06342323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06342323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Optimal Number of Fiducial Marker Implanted With 3D-template Assitance for Stereotactic Body Radiotherapy
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 8, 2023
Completion date
October 7, 2025
Enrollment
57 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer, lung cancer, pancreatic cancer, renal cell carcinoma